NDC 27241-191 Tolterodine Tartrate
Capsule, Extended Release Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 27241 - Ajanta Pharma Usa Inc.
- 27241-191 - Tolterodine Tartrate
Product Characteristics
Product Packages
NDC Code 27241-191-05
Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Price per Unit: $0.37377 per EA
NDC Code 27241-191-30
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Price per Unit: $0.37377 per EA
NDC Code 27241-191-90
Package Description: 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Price per Unit: $0.37377 per EA
Product Details
What is NDC 27241-191?
What are the uses for Tolterodine Tartrate?
What are Tolterodine Tartrate Active Ingredients?
- TOLTERODINE TARTRATE 2 mg/1 - An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE.
Which are Tolterodine Tartrate UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOLTERODINE TARTRATE (UNII: 5T619TQR3R)
- TOLTERODINE (UNII: WHE7A56U7K) (Active Moiety)
Which are Tolterodine Tartrate Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- ETHYLCELLULOSE, UNSPECIFIED (UNII: 7Z8S9VYZ4B)
- MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
- OLEIC ACID (UNII: 2UMI9U37CP)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- SHELLAC (UNII: 46N107B71O)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
What is the NDC to RxNorm Crosswalk for Tolterodine Tartrate?
- RxCUI: 855182 - tolterodine tartrate 2 MG 24HR Extended Release Oral Capsule
- RxCUI: 855182 - 24 HR tolterodine tartrate 2 MG Extended Release Oral Capsule
- RxCUI: 855182 - tolterodine tartrate 2 MG 24 HR Extended Release Oral Capsule
- RxCUI: 855189 - tolterodine tartrate 4 MG 24HR Extended Release Oral Capsule
- RxCUI: 855189 - 24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule
Which are the Pharmacologic Classes for Tolterodine Tartrate?
* Please review the disclaimer below.
Patient Education
Tolterodine
Tolterodine is used treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Tolterodine is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles preventing bladder contraction.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".